Skip to main content
. 2013 Aug 8;81(3):763–775. doi: 10.3797/scipharm.1307-09

Fig. 3.

Fig. 3

Serum glutathione reductase activity in cirrhotic, hepatocellular carcinoma (HCC) patients and control group.